QUEENSWAY MEDICAL CENTRE
QUEENSWAY, POULTON-LE-FYLDE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 23 | 28 | 82.1% | |
| HF 4 | 2011 | 23 | 28 | 82.1% | |
| HF 4 | 2012 | 66 | 83 | 79.5% | |
| HF 4 | 2013 | 68 | 82 | 82.9% | |
| HF004 | 2014 | 34 | 39 | 87.2% | |
| HF004 | 2015 | 33 | 35 | 94.3% | |
| HF004 | 2016 | 28 | 32 | 87.5% | |
| HF004 | 2017 | 24 | 25 | 96.0% | |
| HF004 | 2018 | 25 | 25 | 100.0% | |
| HF004 | 2019 | 29 | 30 | 96.7% | |
| HF004 | 2020 | 110 | 123 | 89.4% | |
| HF006 | 2021 | 127 | 155 | 81.9% | |
| HF006 | 2022 | 138 | 147 | 93.9% | |
| HF006 | 2023 | 138 | 141 | 97.9% |
